Results 141 to 150 of about 136,710 (292)

Association of fully branded, standardized packaging and limited flavor and brand descriptors of e‐liquids with interest in trying products among youths in Great Britain

Addiction, Volume 120, Issue 4, Page 620-628, April 2025.
Abstract Background and aims Many vaping products feature bright colors and novel brand names and flavor descriptors, which may appeal to youth. We measured the strength of the associations between e‐liquid packaging design (branded, white standardized or white standardized limiting brand and flavor descriptors) and perceived peer interest in trying ...
Eve Taylor, Erikas Simonavičius, Matilda Nottage, Ann McNeill, Deborah Arnott, Hazel Cheeseman, David Hammond, Jessica Reid, Pete Driezen, Kimberly D'Mello, Katherine East   +10 more
wiley   +1 more source

Modelling Incentive Salience in Adolescent Substance Use: The Influence of Substance Cues, Alcohol Expectancies and Socio-Environmental Factors. [PDF]

Addict Biol
Gunawan T, Thomas ML, Brumback T, Clark DB, Goldston DB, Nooner KB, Ramchandani VA, Meruelo AD.   +7 more
europepmc   +1 more source

COMPARATIVE ANALYSIS OF MODERN ALCOHOLISM TREATMENT CONCEPTS

, 2017
M. S. Artemyeva, A.V. Maydan
openalex   +1 more source

Parvalbumin interneurons mediate sex differences in prefrontal cortex function. [PDF]

Neuropsychopharmacology
Seney ML, Joffe ME.
europepmc   +1 more source

Examining the role of freebase nicotine in the harm reduction potential of oral nicotine pouches versus moist snuff: A randomized crossover trial

Addiction, EarlyView.
Abstract Background and aims Oral nicotine pouches (ONPs) contain varying proportions of freebase nicotine (FBN), with higher FBN expected to increase nicotine delivery across the oral mucosa. Because ONPs contain fewer toxicants than moist snuff and may serve as a reduced harm alternative for smokeless tobacco, we compared how the FBN in ONPs affects ...
Brittney Keller‐Hamilton, Hayley Curran, Leanne Atkinson, Sriya Suraapaneni, Alice Hinton, Kirsten Chrzan, Darren Mays, Ahmad El‐Hellani, Clark W. Wilson, Marielle C. Brinkman, Theodore L. Wagener   +10 more
wiley   +1 more source

Chronic Alcoholism and Propofol Demand: The Impact of Alcohol Tolerance in Painless Gastrointestinal Endoscopy. [PDF]

JGH Open
Wang X, Shi Y, Yang H, Tao T, Ji J.
europepmc   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Ethnic-Racial Identity and Alcohol Use Moderated by Family Factors among Diverse Emerging Adults. [PDF]

Race Soc Probl
Walker CJ, Williams CD, Santana A, DeLaney EN, Cage J, Su J, Kuo SI, Spit for Science Working Group, Dick DM.   +8 more
europepmc   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source

Effects of GPR110 expression on neurobehavioral outcomes in mice. [PDF]

Front Neurosci
Melkumyan M, Huang BX, Toro J, Kesner A, Kim HY.   +4 more
europepmc   +1 more source